Fintel reports that on April 13, 2023, Canaccord Genuity initiated coverage of Intellia Therapeutics (NASDAQ:NTLA) with a Buy recommendation. Analyst…
Below is Validea's guru fundamental report for INTELLIA THERAPEUTICS INC (NTLA). Of the 22 guru strategies we follow, NTLA rates…